scholarly journals 11P Senescent immune phenotype (SIP) status that predicts resistance to immune checkpoint blockers (ICB) among CMV+ advanced non-small cell lung cancer (aNSCLC) patients is not associated with chronic type I IFN signature

2021 ◽  
Vol 32 ◽  
pp. S1379
Author(s):  
M. Naigeon ◽  
C. de Oliveira ◽  
F-X. Danlos ◽  
B. Duchemann ◽  
P. Saulnier ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Immune Checkpoint ◽  
Small Cell ◽  
Type I ◽  
Type I Ifn ◽  
Small Cell Lung ◽  
Chronic Type ◽  
Immune Checkpoint Blockers

scholarly journals Advances in the prediction of long-term effectiveness of immune checkpoint blockers for non-small-cell lung cancer

Immunotherapy ◽  
2019 ◽  
Vol 11 (12) ◽  
pp. 993-1003 ◽  
Author(s):  
Sara Elena Rebuzzi ◽  
Alessandro Leonetti ◽  
Marcello Tiseo ◽  
Francesco Facchinetti
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Immune Checkpoint ◽  
Small Cell ◽  
Small Cell Lung ◽  
Immune Checkpoint Blockers

scholarly journals P09.25 Role of Immune Checkpoint Inhibitors (ICPi) in KRAS-Mutated Non-Small Cell Lung Cancer (NSCLC)

2021 ◽  
Vol 16 (3) ◽  
pp. S300-S301
Author(s):  
M. Peravali ◽  
C. Gomes-Lima ◽  
E. Tefera ◽  
M. Baker ◽  
M. Sherchan ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Immune Checkpoint ◽  
Immune Checkpoint Inhibitors ◽  
Checkpoint Inhibitors ◽  
Small Cell ◽  
Small Cell Lung
Sign in / Sign up

Export Citation Format

Share Document